Cannasouth offloads assets ahead of Eqalis acquisition

Cannasouth offloads assets ahead of Eqalis acquisition
Staff reporters
Cannasouth has agreed to sell the liquid filling assets of its manufacturing subsidiary, Midwest Pharmaceutics NZ, to Harker Herbal Products for $2.2 million ahead of its potential acquisition of Eqalis.Northland-based Harker Herbals was a supplement retailer that was a key customer for Midwest.Following the potential $48.8m acquisition of Eqalis, which was announced earlier this week, Cannasouth would have access to Eqalis’ facility, which is good manufacturing practice (GMP) compliant for cannabinoids.The divestment will reduce the need...